Drugs / CTA30X
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04689204 | Dec 2020 → Dec 2022 | acute lymphoblastic leukemia | He Huang | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTA30X | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04689204 ↗ |
| Modality | Cell therapy | “CTA30X cell injection” NCT04689204 ↗ |